Peters, S., Liu, S. V., Ganju, V., Kosmider, S., Lee, S., Åžendur, M. A. N., Summers, Y. J., Girard, N., Runglodvatana, Y., Bouchaab, H., Celik, I., Gunaydin, U. M., Bartz, R., Koride, S., Li, L., Gann, C., Åžahin, U., Türeci, Ã., Lu, S. (2025). A global phase 2/3, randomized, open-label trial of BNT327/PM8002 in combination with chemotherapy (chemo) in first-line (1L) non-small cell lung cancer (NSCLC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps8670